75 related articles for article (PubMed ID: 8495423)
1. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
2. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.
Munn DH; Cheung NK
Cancer Immunol Immunother; 1995 Jul; 41(1):46-52. PubMed ID: 7641219
[TBL] [Abstract][Full Text] [Related]
3. Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line.
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Langenhuijsen MM
Cancer Immunol Immunother; 1992; 34(6):393-8. PubMed ID: 1563017
[TBL] [Abstract][Full Text] [Related]
4. N-formyl-methionyl-leucyl-phenylalanine inhibits both gamma interferon- and interleukin-10-induced expression of FcgammaRI on human monocytes.
Beigier-Bompadre M; Barrionuevo P; Alves-Rosa F; Rubel CJ; Palermo MS; Isturiz MA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):402-8. PubMed ID: 11238229
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer-derived microvesicles modulate differentiation of human monocytes to macrophages.
Baj-Krzyworzeka M; Mytar B; Szatanek R; Surmiak M; Węglarczyk K; Baran J; Siedlar M
J Transl Med; 2016 Feb; 14():36. PubMed ID: 26838097
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon gamma and lipopolysaccharide.
Hennemann B; Beckmann G; Eichelmann A; Rehm A; Andreesen R
Cancer Immunol Immunother; 1998 Jan; 45(5):250-6. PubMed ID: 9439648
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent.
Söderberg-Nauclér C; Streblow DN; Fish KN; Allan-Yorke J; Smith PP; Nelson JA
J Virol; 2001 Aug; 75(16):7543-54. PubMed ID: 11462026
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors.
Nakashima H; Miyake K; Clark CR; Bekisz J; Finbloom J; Husain SR; Baron S; Puri RK; Zoon KC
Cancer Immunol Immunother; 2012 Jul; 61(7):1081-92. PubMed ID: 22159517
[TBL] [Abstract][Full Text] [Related]
9. Combination effects of interferon-gamma and cholera toxin on induction of differentiation of an insensitive U-937 clone.
Iwanami M; Takeda K; Iwamoto S; Konno K
Jpn J Cancer Res; 1990 May; 81(5):520-6. PubMed ID: 2166023
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway.
Fogg KC; Miller AE; Li Y; Flanigan W; Walker A; O'Shea A; Kendziorski C; Kreeger PK
BMC Cancer; 2020 Oct; 20(1):1008. PubMed ID: 33069212
[TBL] [Abstract][Full Text] [Related]
11. Effects of temporal IFNγ exposure on macrophage phenotype and secretory profile: exploring GMP-Compliant production of a novel subtype of regulatory macrophages (Mreg
Zitta K; Hummitzsch L; Lichte F; Fändrich F; Steinfath M; Eimer C; Kapahnke S; Buerger M; Hess K; Rusch M; Rusch R; Berndt R; Albrecht M
J Transl Med; 2024 Jun; 22(1):534. PubMed ID: 38835045
[TBL] [Abstract][Full Text] [Related]
12. Identification of factor XIII-A as a marker of alternative macrophage activation.
Töröcsik D; Bárdos H; Nagy L; Adány R
Cell Mol Life Sci; 2005 Sep; 62(18):2132-9. PubMed ID: 16132226
[TBL] [Abstract][Full Text] [Related]
13. Monocyte polarization: the relationship of genome-wide changes in H4 acetylation with polarization.
Zhang Z; Song L; Maurer K; Bagashev A; Sullivan KE
Genes Immun; 2011 Sep; 12(6):445-56. PubMed ID: 21451557
[TBL] [Abstract][Full Text] [Related]
14. Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.
Koff WC; Fogler WE; Gutterman J; Fidler IJ
Cancer Immunol Immunother; 1985; 19(2):85-9. PubMed ID: 3921232
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro.
Parry HJ; Rees RC
Cancer Immunol Immunother; 1992; 34(6):355-60. PubMed ID: 1563012
[TBL] [Abstract][Full Text] [Related]
16. Nano(bio)Materials Do Not Affect Macrophage Phenotype-A Study Conducted by the REFINE Project.
David CAW; Vermeulen JP; Gioria S; Vandebriel RJ; Liptrott NJ
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791527
[TBL] [Abstract][Full Text] [Related]
17. Regulatory macrophages in solid organ xenotransplantation.
Hoang TX; Kim JY
Korean J Transplant; 2023 Dec; 37(4):229-240. PubMed ID: 38115165
[TBL] [Abstract][Full Text] [Related]
18. Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice.
Davison LM; Liu JC; Huang L; Carroll TM; Mellor AL; Jørgensen TN
Front Immunol; 2019; 10():2017. PubMed ID: 31555267
[TBL] [Abstract][Full Text] [Related]
19. Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway.
de Oliveira FR; Fantucci MZ; Adriano L; Valim V; Cunha TM; Louzada-Junior P; Rocha EM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544839
[TBL] [Abstract][Full Text] [Related]
20. IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production.
Yue Y; Huang W; Liang J; Guo J; Ji J; Yao Y; Zheng M; Cai Z; Lu L; Wang J
PLoS One; 2015; 10(11):e0142979. PubMed ID: 26599209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
